- Investing.com
Metrics to compare | 4540 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship4540PeersSector | |
|---|---|---|---|---|
P/E Ratio | 9.3x | 15.8x | −0.4x | |
PEG Ratio | 0.47 | 0.11 | 0.00 | |
Price/Book | 0.9x | 1.2x | 2.6x | |
Price / LTM Sales | 1.4x | 1.7x | 3.1x | |
Upside (Analyst Target) | 8.7% | 14.8% | 48.5% | |
Fair Value Upside | Unlock | 13.9% | 5.8% | Unlock |
Tsumura & Co. engages in the production and sale of Kampo extract intermediates and granular Kampo formulations in Japan and internationally. The company offers products for female problems, proneness to fatigue, skin problems, gastrointestinal problems, obesity, constipation and hemorrhoids, as well as body aches, children's sickness, stress, urinary problems, and cold, cough, and nasal/throat inflammation symptoms. It is also involved in manufacturing and sales of prescription drugs and over-the-counter Kampo medicines. Tsumura & Co. was founded in 1893 and is headquartered in Tokyo, Japan.